Inactive Instrument

Caribbean International Holdings Inc Share Price Other OTC

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

05-14	Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M	MT
2023	NovaBay to Commercialize BioStem's Amniotic Tissue Allograft	MT

Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M	05-14	MT
NovaBay to Commercialize BioStem's Amniotic Tissue Allograft	11/09/23	MT

BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments	01:15pm	NE
BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)	01:02pm	AQ
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)	09:34am	AQ
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers	07-10	AQ
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study	06-26	AQ

Managers	Title	Age	Since
Andrew van Vurst FOU	Founder	-	06/07/06
Jason Matuszewski CEO	Chief Executive Officer	-	06/07/06
Michael Fortunato DFI	Director of Finance/CFO	-	31/12/20

Members of the board	Title	Age	Since
Thomas Dugan CHM	Chairman	66	12-12
Patrick Daly BRD	Director/Board Member	-	12-18
Jason Matuszewski CEO	Chief Executive Officer	-	06/07/06

Sector

Calendar

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+20.17%	127B
REGENERON PHARMACEUTICALS, INC.	+24.67%	117B
ARGENX SE	+25.44%	27.67B
BIONTECH SE	-17.74%	20.33B
GENMAB A/S	-15.17%	16.79B
BEIGENE, LTD.	-15.21%	15.63B
NEUROCRINE BIOSCIENCES, INC.	+11.91%	14.84B
WUXI APPTEC CO., LTD.	-47.10%	14.65B
SAREPTA THERAPEUTICS, INC.	+54.50%	14.43B